Table 1. Patient characteristics.
| Patient characteristics | |
|---|---|
| Age | 46.7 (18–78) |
| Gender, n (%) | |
| Female | 32 |
| Male | 58 |
| Response to salvage therapy, n (%) | |
| CR | 32 (36) |
| PR | 55 (61) |
| SD/PD | 3 (3) |
| Type of lymphoma, n (%) | |
| NHL | 60 (67) |
| Int/high-grade B-cell lymphoma | 50 |
| Mantle cell | 4 |
| T cell/anaplastic | 6 |
| Hodgkins lymphoma | 30 (33) |
| Additional radiotherapy, n (%) | 18 |
| Pre-txp PET positive | 26/67 (39%) |
| Post-txp PET positive | 20/70 (29%) |
| Stage at relapse, n (%) | |
| I | 1 |
| II | 13 |
| III | 18 |
| IV | 24 |
| Refractory disease | 30 |
| Transplanted in first CR | 3 |
| Missing | 1 |
| Conditioning regimen | |
| CVB | 72 |
| BEAM | 10 |
| Other | 4 |
| Missing | 4 |
| Both pre-PET and post-PET | 47 |
| Positive-negative | 7 |
| Positive-positive | 8 |
| Negative-negative | 26 |
| Negative-positive | 6 |
| Post transplant events, n (%) | |
| Experienced disease relapse | 34 (37%) |
| Death from disease | 25 (27%) |
| Post transplant therapy | 20 (22%) |
| Radiation | 17 |
| Rituximab | 3 |
| Recommended, but not done | 10 |
| None | 60 |
Abbreviations: NHL=non-Hodgkins lymphoma; PET=positron emission tomography.